Home › Funds › Two Sigma Investments › ELDN
Two Sigma Investments position in ELDN
ELEDON PHARMACEUTICALS INC · Health Care
Latest position (Q2 2026)32.95K sh
Reported value held$129.80K
Portfolio Weight0.00%
First reportedQ3 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 115.32K | $713.00K | New |
| Q4 2021 | 125.19K | $552.00K | Add |
| Q1 2022 | 68.49K | $270.00K | Reduce |
| Q2 2022 | 31.14K | $76.00K | Reduce |
| Q3 2022 | 29.74K | $82.00K | Reduce |
| Q4 2022 | 21.64K | $49.33K | Reduce |
| Q1 2023 | 17.59K | $41.50K | Reduce |
| Q2 2023 | 10.59K | $14.50K | Reduce |
| Q2 2026 | 32.95K | $129.80K | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding ELDN
- BlackRock Inc 5.12M sh · $20.19M · Q2 2026
- Goldman Sachs Group 2.51M sh · $9.89M · Q2 2026
- Geode Capital Management 1.96M sh · $7.71M · Q2 2026
- Vanguard Group 4.04M sh · $6.10M · Q4 2025
- UBS Group AG 1.05M sh · $4.13M · Q2 2026
- Millennium Management 979.71K sh · $3.86M · Q2 2026
- Bank of America Corp 883.10K sh · $3.48M · Q2 2026
- Northern Trust Corp 616.40K sh · $2.43M · Q2 2026
- AQR Capital Management 581.03K sh · $2.29M · Q2 2026
- Citadel Advisors 510.67K sh · $2.01M · Q2 2026
- Morgan Stanley 485.09K sh · $1.91M · Q2 2026
- Charles Schwab Investment Management 247.40K sh · $974.77K · Q2 2026